More than 20% of patients who take Paxlovid experience a virologic rebound of COVID-19 after stopping treatment, according to research published Nov. 13 in the Annals of Internal Medicine.
Walnut Creek, Calif.-based John Muir Health is partnering with Ambience Healthcare, a healthcare artificial intelligence company, to integrate its generative AI scribe within its Epic EHR.
A year after the FDA found shredded quality documents at an Intas Pharmaceuticals drug manufacturing facility in India, Intas’ parent company Accord Healthcare resumed making cisplatin, which has been in dire shortage for months.
Grand Rapids, Mich.-based Corewell Health reported revenue of $11.2 billion in the first nine months of 2023, an 11.6% increase on the previous year’s period.